Dualitas Therapeutics Dualitas Therapeutics is pioneering the future of bispecific antibody therapies. Driven by its DualScreen discovery engine, Dualitas is advancing novel bispecific antibody therapies for immunological and inflammatory disease.
Investors 1
| Date | Name | Website |
| - | Chugai Ven... | chugaivent... |
Mentions in press and media 2
| Date | Title | Description |
| 16.09.2025 | Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease | - |
| - | Dualitas Therapeutics | “Dualitas Therapeutics is a biotechnology company pioneering best-in-class, next-generation bispecific antibodies for immune and inflammatory diseases and beyond. ” |